Health Care • Medical/Dental Instruments
$0.40 ▼ -0.05
(-10.49%)
MKT CAP: $3.5M • VOL: 553.9K
52W L $0 52W H $14
ROARABLE / RQD
D- • 37/100
PIOTROSKI
3 / 9
CODX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $622.5K | $3.9M | $6.8M |
| YoY Revenue Growth % | -84.1% | -42.5% | — |
| Gross Profit | $400.1K | $2.9M | — |
| Gross Margin % | 64.3% | 74.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$50.2M | -$40.1M | -$42.7M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$47.0M | -$38.0M | -$35.3M |
| EBITDA (Normalized) | -$49.6M | -$39.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$29.1M | -$29.2M | -$22.1M |
| Capital Expenditures (CapEx) | $700.0K | $748.4K | — |
| Free Cash Flow (FCF) | -$29.8M | -$29.9M | -$22.1M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $11.9M | $2.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $20.6M | $53.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CODX.